Chronic Granulomatous Disease (CGD): Commonly Associated Pathogens, Diagnosis and Treatment.
Angel A Justiz-VaillantArlene Faye-Ann Williams-PersadRodolfo Arozarena-FundoraDarren GopaulSachin SoodeenOdalis Asin-MilanReinand ThompsonChandrashekhar UnakalPatrick Eberechi AkpakaPublished in: Microorganisms (2023)
Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by a defect in the phagocytic function of the innate immune system owing to mutations in genes encoding the five subunits of the nicotinamide adenine dinucleotide phosphatase (NADPH) oxidase enzyme complex. This review aimed to provide a comprehensive approach to the pathogens associated with chronic granulomatous disease (CGD) and its management. Patients with CGD, often children, have recurrent life-threatening infections and may develop infectious or inflammatory complications. The most common microorganisms observed in the patients with CGD are Staphylococcus aureus , Aspergillus spp., Candida spp., Nocardia spp., Burkholderia spp., Serratia spp., and Salmonella spp. Antibacterial prophylaxis with trimethoprim-sulfamethoxazole, antifungal prophylaxis usually with itraconazole, and interferon gamma immunotherapy have been successfully used in reducing infection in CGD. Haematopoietic stem cell transplantation (HCT) have been successfully proven to be the treatment of choice in patients with CGD.
Keyphrases
- stem cell transplantation
- staphylococcus aureus
- escherichia coli
- high dose
- immune response
- interstitial lung disease
- gram negative
- young adults
- biofilm formation
- antimicrobial resistance
- rheumatoid arthritis
- low dose
- microbial community
- multidrug resistant
- cell proliferation
- smoking cessation
- cell cycle arrest
- pi k akt
- replacement therapy